Salesforce: Depressed Multiple and Massive Buyback Signal Turning Point

What happened

Salesforce stock has fallen ~42% from highs to ~$156.70, now trading at ~11x trailing FCF, reflecting AI disruption fears. Management executed a $24.8B debt-funded buyback in Q1 FY2027, reducing share count by over 10% and signaling undervaluation. The company’s core business remains strong with 20.1% GAAP operating margin, $15B operating cash flow, and $67.9B remaining performance obligations. The key debate is whether AI agents (Agentforce) cannibalize seat-based revenue or drive incremental spend, with near-term proof points in seat growth and the July 2026 pay-per-resolution launch. The base-case scenario suggests ~14% annualized return with limited downside given backlog and cash generation, but the debt-funded buyback increases balance sheet risk.

Implication

The depressed valuation and massive buyback create an asymmetric risk/reward if AI monetization proves additive. However, leverage from debt-funded buybacks reduces the safety margin and increases sensitivity to any guidance miss. The thesis hinges on seat growth remaining positive and Agentforce ARR exceeding $1.3B by Q3 FY27. If cannibalization fears are unfounded, the stock could re-rate to ~$185-240. If not, downside to $120 is possible, but supported by strong cash flows and contractual backlog.

Thesis delta

The core thesis shifts from outright AI disruption risk to a more balanced view with identifiable catalysts. The buyback and continued seat growth in Q1 FY27 suggest management sees value, while the July 2026 pay-per-resolution launch and upcoming earnings will provide critical proof points. The risk is that debt overhang and AI pricing complexity keep multiples depressed until clarity emerges, but the upside potential is compelling if Agentforce proves additive.